We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.48B
AUM Growth
-$217M
(-4.6%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-9.3%
Top 10 Holdings %
Top 10 Hldgs %
80.33%
Holding
67
New
7
Increased
4
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$104M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$29.3M |
| 3 |
Roivant Sciences
ROIV
|
+$21.8M |
| 4 |
Neumora Therapeutics
NMRA
|
+$21.2M |
| 5 |
Sagimet Biosciences
SGMT
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$113M |
| 2 |
KE Holdings
BEKE
|
+$81.9M |
| 3 |
JD.com
JD
|
+$76.4M |
| 4 |
Pinduoduo
PDD
|
+$70.8M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$58.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.88% |
| 2 | Consumer Discretionary | 31.35% |
| 3 | Technology | 13.19% |
| 4 | Real Estate | 10.63% |
| 5 | Communication Services | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aligos Therapeutics
ALGS
$26.3M
| $1.73M | 0.04% |
92,391
| – | – |
|
|
BEDU
52
DELISTED
Bright Scholar Education Holdings
BEDU
| $1.14M | 0.03% |
988,143
-4,900
| -0.5% | -$5.37K |
|
53
Pyxis Oncology
PYXS
$185M
| $761K | 0.02% |
382,606
| – | – |
|
54
Playtika
PLTK
$1.53B
| $701K | 0.02% |
72,800
| – | – |
|
55
iQIYI
IQ
$1.19B
| $675K | 0.02% |
142,500
| – | – |
|
|
LSB
56
DELISTED
LakeShore Biopharma
LSB
| $601K | 0.01% |
75,179
| – | – |
|
|
AMAM
57
DELISTED
Ambrx Biopharma Inc
AMAM
| $365K | 0.01% |
+31,735
| New | +$432K |
|
|
UXIN
58
Uxin Ltd
UXIN
$306M
| $312K | 0.01% |
19,156
| – | – |
|
|
RDGT
59
Ridgetech Inc
RDGT
$692K
| $96K | ﹤0.01% |
134
| – | – |
|
60
Surrozen Inc Warrant
SRZNW
$36.6K
| $15.8K | ﹤0.01% |
384,573
-2,560
| -0.7% | -$119 |
|
61
Adobe
ADBE
$105B
| – | – |
-27,000
| Closed | -$13.2M |
|
62
Advanced Micro Devices
AMD
$700B
| – | – |
-40,500
| Closed | -$4.61M |
|
63
Coinbase
COIN
$42.2B
| – | – |
-100,000
| Closed | -$7.16M |
|
64
Alphabet (Google) Class C
GOOG
$4.11T
| – | – |
-100,000
| Closed | -$12.1M |
|
|
HOOK
65
DELISTED
HOOKIPA Pharma
HOOK
| – | – |
-77,072
| Closed | -$678K |
|
66
Keurig Dr Pepper
KDP
$42.8B
| – | – |
-564,568
| Closed | -$17.7M |
|
67
Li Auto
LI
$14.4B
| – | – |
-170,704
| Closed | -$5.99M |
|
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, HHLR Advisors held 67 positions worth $4.48B, down 4.6% from $4.7B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
HHLR Advisors withdrew a net $417M in Q3 2023, closing 7 positions and reducing 20 holdings. Its most notable exit was Keurig Dr Pepper, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, HHLR Advisors opened a new position in RayzeBio, Inc. Common Stock worth $31M.
- HHLR Advisors's largest Q3 2023 buy was RayzeBio, Inc. Common Stock: 1,395,716 shares worth $31M.
- HHLR Advisors added most to Amazon in Q3 2023, an estimated $104M increase.
- HHLR Advisors's biggest Q3 2023 reduction was Alibaba, cutting an estimated $113M.
- HHLR Advisors fully exited Keurig Dr Pepper in Q3 2023, selling an estimated $17.7M.
- HHLR Advisors's ten largest holdings make up 80% of its $4.48B portfolio in Q3 2023.
- HHLR Advisors opened 7 new positions and closed 7 in Q3 2023.
- HHLR Advisors's portfolio value fell 4.6% quarter-over-quarter to $4.48B.
Based on HHLR Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.